Optical Imaging Market Technology Trends And Applications Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis – (2013-2018)
Released On 20th June 2014
Optical Imaging is an emerging medical technology that uses light to assess optical properties of tissues, and has a great potential for improving disease prevention, clinical research, medical diagnosis and treatment. The basic principle involves the detection of emitted photons at pre-defined wavelength ranges when the fluorescent probes in the optical imaging system can be excited by NIR light. Further advancements and breakthroughs in the field of fiber optics and photonics resulted in the emergence of innovative technologies such as Optical Coherence Tomography (OCT), Photo-Acoustic Tomography (PAT), Hyper-Spectral Imaging (HSI) and Near-Infrared Spectroscopy (NIRS) that have a potential to redefine the fields of clinical diagnostics and research. These technologies have an ability distinguish the diverse soft tissues based on photon absorption and scattering differences among the soft tissues enhancing the accuracy of clinical research and pathological diagnosis. Though these technologies are still in the early phase of development, they offer a number of advantages (such as non-invasiveness and use of no ionizing radiation) over existing radiological screening techniques.
Buy this report OR Know more : http://www.jsbmarketresearch.com/healthcare-medical/r-Optical-Imaging-Market-Technology-Trends-and-Applications-of-Optical-Coherence-Tomography-OCT-63691
This research report is categorized into OCT, PAT, HSI and NIRS and is further classified as follows-
Global optical imaging market is anticipated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major markets followed by Europe, and have been driving the market significantly owing to the increase in aging population across the developed economies. Emerging economies such as Asia-pacific and Middle-East are the future drivers of this market.
This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service.
Multi-modality imaging using fibre-optics principles boosts the development of novel therapeutics and early detection of chronic diseases. Advancements in these modalities enable clinicians to visualize better views of anatomical structure and function, both at the molecular and cellular levels.
Drivers:
A key driving force is the technologys immense application scope for easy access to visualize and image in-depth structures of eye, surface tissues, mucosal membranes, the gastrointestinal tract, and vascular systems. They also enhance the drug discovery process by enabling better imaging of tissues and other biological entities at the molecular level. A major advantage of using optical imaging includes operator safety, patient comfort and patient safety. In the future, most of these technologies will gain widespread clinical acceptance and find specific roles in the clinical medicine.
Challenges:
Inadequate clinical data validation for optical methods restricts adoption.
Lack of reimbursement facilities.
The key players profiled in the report are Michelson Diagnostics, Heidelberg Engineering GmBH, Carl Zeiss Meditec, Volcano Corporation, Topcon Medical Systems Inc., St. Jude Medical Inc., Headwall Photonics, Cytoviva Inc., ChemImage Corporation, Bioptigen Inc., Raytheon ELCAN Optical Technologies, Somanetics Corporation and ASE Optics Inc.
Scope of the Report:
The research service on Advances in Optical Imaging in Clinical Diagnostics & Clinical Research Technology Trends and Market Landscape Analysis is an attempt to showcase the technology and market impact of existing and emerging fibre-optics based technologies having an immense growth potential in clinical medicine for the next five years. This technology based research report categorizes optical imaging market based on technology, applications and based on geography.
Based on Technology: : The report covers the technical aspects of OCT, PAT, NIRS and HSI along with investment potentials. Quantitative data analysis and growth rates of OCT are provided for the North America and European regions and potential addressable market for other technology segments are mentioned in the report.
Based on Geography: The technologies in this report were thoroughly based on geographies North America, Europe, Asia, and Rest of the World (ROW) providing in-depth information on market size, share and segmentation. The report also provides information on adoption and development potential of OCT, HSI, NIRS and PAT technologies in these regions.
Reasons to buy the Report
This report service on optical imaging in clinical medicine comprehends 75% of its focus on technological understanding and 25% of market engineering standards. There is only one recent available report on Optical Imaging Devices and it does not include market numbers. So this report would be the first holistic report which analyses in depth about technology as well as market landscape of optical imaging market.
Table of Content:
1 Introduction (Slide No.14-23)
1.1 Key Take- Aways
1.2 Report Scope
1.3 Report Segmentation
1.4 Research Methodology
1.5 Assumptions
2 Summary (Slide No.24-28)
3 Technology Snapshot (Slide No.29-49)
3.1 Technology Overview
3.2 Optical Imaging In Clinical Medicine For The U.S. And Eu Regions
3.3 Technology Trends
3.4 Technology Segmentation
3.5 Commercially Available Modalities
3.6 Optical Imaging Modalities Vs Conventional Modalities
3.7 Optical Coherence Tomography (Oct)
3.8 Hyper Spectral Imaging (Hsi)
3.9 Near Infrared Spectroscopy (Nirs)
3.10 Photo- Acoustic Tomography (Pat)
3.11 Technology Roadmap
3.12 Technology Scope
-Oct
3.13 Technology Scope
Hyper Spectral Imaging & Near Infrared Spectroscopy
4 Value Chain Analysis (Slide No.49-52)
5 Market Landscape Analysis (Slide No.53-73)
5.1 Market Landscape Analysis-Overview
5.1.1 Market Evaluation & Assessment, By Technology
5.1.2 Market Evaluation & Assessment, By Geography
5.1.3 Market Evaluation & Assessment, By Applications
5.2 U.S. Oct Market Landscape Analysis
5.2.1 U.S. Oct For Clinical Diagnostics -Ophthalmology, Dentistry, Cardiology, Dermatology, Oncology & Others
5.2.2 U.S. Oct For Clinical Research & Life Sciences For Biomedical Research, Drug Discovery & Pre-Clinical Imaging
5.3 European Union Oct Market Landscape Analysis
5.3.1 European Union Oct For Clinical Diagnostics -Ophthalmology, Dentistry, Cardiology, Dermatology, Oncology & Others
5.3.2 European Union Oct For Clinical Research & Life Sciences For Biomedical Research, Drug Discovery & Pre-Clinical Imaging
5.4 Market Dynamics
5.4.1 Drivers
5.4.2 Restraints
6 Regulatory Landscape Analysis (Slide No.74-78)
6.1 Regulatory Landscape Analysis Overview
6.1.1 Regulatory Analysis Region Wise
6.1.2 Regulatory Landscape Analysis Country Wise
7 Technology Adoption & Development Potential By Geography (Slide No.79-84)
7.1 Geographic Adoption & Development Potential
7.1.1 Americas
7.1.2 Europe
7.1.3 Row
8 Investor Analysis & Investment Opportunities (Slide No.85-95)
8.1 Investor Network – Federal Funding Agencies, Regional Government Funding, Corporate Investors, Venture Capitalists & Private Equity Firms
8.2 Oct Funding
8.3 Oct National Institute Of Health/National Science Foundation/European Commission Funding, By University
8.4 Hyper Spectral Imaging, Near Infrared Spectroscopy & Photo- Acoustic Tomography Funding
8.5 Potential Investment Opportunities
9 Competitive Landscape Analysis (Slide No.96-113)
9.1 Key Company Market Share
9.2 Key Mergers & Acquisitions (2009-2012)
9.3 Key Partnerships/Agreements/Collaborations (2009-2012)
9.4 Key Product Launches (2009-2012)
9.5 Oct Competitive Analysis
10 Analyst Insights & Recommendations (Slide No.114-118)
10.1 Analyst Insights
10.1.1 Analyst Insights By Technology
10.1.2 Business Strategies Based Analyst Insights
10.1.3 Analyst Recommendations
11 Company Profiles (Slide No.119-143)
11.1 Michelson Diagnostics Ltd ( Vivosight)
11.2 Carl Zeiss Meditec
11.3 Heidelberg Engineering
11.4 St. Jude Medical
11.5 Volcano Corporation
11.6 Headwall Photonics, Inc.
11.7 Raytheon Elcan Optical Technologies
11.8 Chemimage Corporation
11.9 Cytoviva, Inc.
11.10 Somanetics Corporation
11.11 Topcon Medical Systems, Inc.
11.12 Ase Optics
11.13 Bioptigen, Inc.
12 Appendix (Slide No.144-145)
List Of Tables (10 Tables)
1 Global Optical Imaging Market (2011-2018)- By Technology, By Revenue ($Million)
2 Global Oct Market (2011-2018)- By Geography, By Revenue ($Million)
3 Optical Imaging Market (2011-2018)- By Geography, By Revenue ($Million)
4 Optical Imaging Market (2011-2018)- By Applications, By Revenue ($Million)
5 U.S. Optical Coherence Tomography Market (2011-2018)- By Applications, By Revenue ($Million)
6 U.S. Optical Coherence Tomography For Clinical Diagnostics (2011-2018)- By Applications, By Revenue ($Million)
7 U.S. Optical Coherence Tomography For Clinical Research (2011-2018)- By Applications, By Revenue ($Million)
8 Eu Optical Coherence Tomography Market (2011-2018)- By Applications, By Revenue ($Million)
9 Eu Optical Coherence Tomography For Clinical Diagnostics (2011-2018)- By Applications, By Revenue ($Million)
10 European Union Optical Coherence Tomography For Clinical Research (2011-2018)- By Applications ,By Revenue ($Million)
List Of Figures (36 Figures)
1 Global Optical Imaging Market, By Technology, By Revenues, 2011-2018 ($Million)
2 Optical Imaging Market Share, 2012, By Technology
3 Global Optical Imaging Market, By Geography, By Revenues (2012-2018)
4 Optical Imaging Market Growth Forecast, By Geography (2012-2018)
5 U.S. Oct- Clinical Diagnostics Market 2012, By Applications
6 European Union Oct For Clinical Diagnostics (2011-2018) By Applications, By Revenues ($Million)
7 Global Optical Imaging Market (2011-2018), By Market Revenues ($Million)
8 Global Optical Imaging Market Forecast(2011-2018), By Technology, By Revenues ($Million)
9 Global Oct Market (2011-2018), By Revenues ($Million)
10 Hyper Spectral Imaging Market (2011-2018), By Revenues ($Million)
11 Near Infrared Spectroscopy & Photo- Acoustic Tomography Market (2011- 2018), By Revenues ($Million)
12 Optical Imaging Market 2012 , By Technology
13 Global Oct Market (2011-2018), By Geography, By Revenues
14 Optical Imaging Market 2012, By Geography
15 Optical Imaging Technologies, By Applications, By Revenues (2012-2018)
16 U.S. Oct Market 2012, By Applications
17 U.S. Oct Clinical Diagnostics Market 2012, By Applications
18 U.S. Oct For Clinical Diagnostics (2011-2018), By Applications, By Revenues ($Million)
19 U.S. Oct For Clinical Research (2011-2018), By Applications, By Market Share ($Million)
20 U.S. Oct For Lifesciences Research (2011-2018) , By Applications, By Market Share ($Million)
21 European Union Oct Market (2011-2018), By Applications
22 European Union Oct Clinical Diagnostics Market (2011-2018), By Applications, By Revenues ($Million)
23 European Union Oct Clinical Diagnostics Market Share 2012, By Ap Applications
24 European Union Oct For Clinical Research (2011-2018), By Applications, By Revenues ($Million)
25 European Union Oct For Lifesciences Research (2011-2018), By Applications, By Revenues ($Million)
26 Regulatory Landscape
27 Optical Maging Market, By Geography, 2013 2018 (Cagr%)
28 Investors Network – Federal Funding Agencies, Regional Government Funding,Corporate Investors, Venture Capitalists & Private Equity Firms
29 Investors Funding 2012
30 Year-Wise National Institute Of Health Funding ($Million)
31 European Commission, National Science Foundation & Canadian Funding ($Million)
32 Potential Investment Opportunities
33 Competitive Landscape
34 Key Company Market Share
35 Oct Competitive Landscape Analysis (2012)
36 No. Of Oct Companies (2008-2013)
Related reports:
* Orion Corporation (ORNBV) – Financial and Strategic SWOT Analysis Review
* North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft – Forecast to 2018
* BioLineRx, Ltd. (BLRX) – Financial and Strategic SWOT Analysis Review
About JSB Market Research:-
JSB market research is a leading player in the market of research report distribution. It is one-stop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on “Optical Imaging Market Technology Trends And Applications Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis – (2013-2018)”
http://www.jsbmarketresearch.com/healthcare-medical/r-Optical-Imaging-Market-Technology-Trends-and-Applications-of-Optical-Coherence-Tomography-OCT-63691